Pharmacoefficiency

Pomalidomide. Pharmacoeconomic analysis

October 17, 2016
The material presents a pharmacoeconomic evaluation of the use of the drug pologidomide for the treatment of patients with recurrent and refractory multiple myeloma.

Uncontrolled bronchial asthma. Pharmacoeconomic analysis

October 04, 2016
Bronchial asthma is a chronic inflammatory disease of the respiratory tract with a high prevalence all over the world, including in the Russian Federation.A significant problem is the uncontrolled course of this disease, which is observed in 40-67% of patients. In this case, in addition to clinical difficulties, the economic aspect is also acute, because the treatment of uncontrolled bronchial asthma involves significant financial

Treatment of Multiple Sclerosis - Pharmacoeconomic Analysis

September 19, 2016
The results of epidemiological cross-sectional studies suggest that at least 150,000 people with multiple sclerosis live in Russia. This disease, as a rule, affects young people and leads to permanent disability. However, this economic damage is not exhausted: almost all drugs that use for the treatment of multiple sclerosis have a very high cost. This is especially true for innovative

Antibiotics for complicated skin and soft tissue infections - pharmacoeconomic analysis

September 19, 2016
Staphylococcus aureus (S. aureus) is one of the main pathogens of skin and soft tissue infections, primarily nosocomial infections. Treatment of such infections is significantly complicated by the wide spread of strains of staphylococcus, resistant to oxacillin and methicillin (ORSA and MRSA).On the pharmaceutical market there are several drugs that are effective against the above-described resistant strains. They all have a high
  • 1